Active

Claret Capital Partners

General contacts

Investor type

Debt fund / VC / PE

Founded

2013

AUM

$1 300 M

Location

London, England, United Kingdom

Investment Ticket

$50-100 m

Investment Stage

Late Stage (Series C+)

Region of investment

Europe

Investor profile last updated: 08 September, 2026

Profile

Claret Capital Partners is a growth debt investor based in London, founded in 2013. With a team expanding into Paris and Berlin, the firm is focused on providing flexible financing solutions to its portfolio companies. The team, including Managing Partner Johan Kampe, prides itself on addressing the needs of entrepreneurs seeking non-dilutive capital solutions in a selective equity market environment. Claret sets itself apart with discretionary co-investment partnerships that allow it to participate in larger deals.

Claret focuses on technology, life sciences, and impact sectors, offering tailored growth capital solutions without demanding significant equity dilution. It invests across Europe, primarily targeting expansion, acquisitions, and product development financing needs. Since its inception, the firm has raised €1.3 billion and deployed over €1.5 billion. Notable funds include the €297 million Fund III closed in 2022 and the recently closed €575 million Fund IV. The firm's investor base comprises pension funds, insurers, family offices, and institutional investors.

Some of the firm's notable portfolio companies include Billie - B2B payments platform, Cinclus Pharma - pharmaceuticals, Inventiva - biotech, and Surfe - sales intelligence platform. Additionally, Fund III supported companies like Cytora and Endomag. The firm continues to seek out and develop strategic partnerships to enhance its financing capabilities across Europe.

Industry

AI MedTech Technology Life Sciences Healthcare Services Consumer Products Biotechnology Business Services (B2B) Fintech Pharmaceuticals

Claret Capital Partners Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Claret European Growth Capital Fund IV	Private Equity (PE) Venture Capital (VC) Debt fund	Technology Life Sciences	Late Stage (Series C+)	Europe	$50-100 m	$632.5 M	September 2026

Contacts

Name

Title

Social Networks

David Bateman Managing Partner

Managing Partner

d•••@•••

Johan Kampe Managing Partner

Managing Partner

j•••@•••

Upgrade to see contacts

EW9wPusUIdSCq1vA EW9wPusUIdSCq1vA

EW9wPusUIdSCq1vA

[email protected]

EW9wPusUIdSCq1vA EW9wPusUIdSCq1vA

EW9wPusUIdSCq1vA

[email protected]

EW9wPusUIdSCq1vA EW9wPusUIdSCq1vA

EW9wPusUIdSCq1vA

[email protected]

Investment-team contacts for Claret Capital Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Claret Capital Partners

Is Claret Capital Partners a venture capital or private equity firm?

Claret Capital Partners is a venture capital and private equity firm that also operates as a debt fund. It backs companies at Late Stage (Series C+), writing tickets of $50-100 m.

Where is Claret Capital Partners located?

Claret Capital Partners is located in London, England, United Kingdom.

When was Claret Capital Partners founded?

Claret Capital Partners was founded in 2013.

What sectors and industries does Claret Capital Partners invest in?

Claret Capital Partners invests in companies and startups in AI, MedTech, Technology, Life Sciences, Healthcare Services, Consumer Products, Biotechnology, Business Services (B2B), Fintech, Pharmaceuticals.

What is Claret Capital Partners geographical focus of investments?

Claret Capital Partners invests in companies and startups in Europe.

At what stages of companies and startups does Claret Capital Partners typically invest in?

Claret Capital Partners invests in companies and startups at Late Stage (Series C+).

What is the usual amount of Claret Capital Partners investment?

Claret Capital Partners usually invests $50-100 m on average.

What is the amount of assets of under management (AUM) for Claret Capital Partners?

Claret Capital Partners has around $1 300m assets under management.

When was Claret Capital Partners last fund created?

Claret Capital Partners last fund was created/launched in 2026-09-07

What are the contacts of Claret Capital Partners?

Claret Capital Partners can be reached through its website claret-capital.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Claret Capital Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Claret Capital Partners data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Claret Capital Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Claret Capital Partners profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 08 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.